12.51

2.37% 0.29

After Hours: 12.51

Day One Biopharmaceuticals Inc (DAWN)

Overview News Price History Option Chain Financials Discussions Forecast

Day One Biopharmaceuticals Inc stock is traded at $12.51, with a volume of 988.01K. It is up +2.37% in the last 24 hours and up +2.54% over the past month. Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor.

Previous Close:

$12.22

Open:

$12.24

24h Volume:

988.01K

Relative Volume:

0.90

Market Cap:

$1.26B

Revenue:

Net Income/Loss:

$-167.48M

P/E Ratio:

-6.4154

EPS:

-1.95

Net Cash Flow:

$-197.47M

1W Performance:

-2.72%

1M Performance:

+2.54%

6M Performance:

-4.58%

1Y Performance:

-20.97%

1-Day Range:

$12.02

$12.65

1-Week Range:

$11.93

$13.01

52-Week Range:

$11.13

$18.07

Day One Biopharmaceuticals Inc Stock (DAWN) Company Profile

Name

Day One Biopharmaceuticals Inc

Sector

Healthcare (1177)

Industry

Biotechnology (679)

Phone

650 484-0899

Address

2000 SIERRA POINT PARKWAY, SUITE 501, BRISBANE

Employee

174

Twitter

Next Earnings Date

Latest SEC Filings

DAWN's Discussions on Twitter

Compare DAWN with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DAWN Day One Biopharmaceuticals Inc	12.51	1.26B	0	-167.48M	-197.47M	-1.95
VRTX Vertex Pharmaceuticals Inc	481.16	123.91B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	722.07	78.94B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	657.97	39.98B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	278.25	35.89B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	119.94	28.75B	3.30B	-501.07M	1.03B	-2.1146

Day One Biopharmaceuticals Inc Stock (DAWN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-09-24	Reiterated	Needham	Buy
Aug-01-24	Upgrade	BofA Securities	Underperform → Buy
Apr-24-24	Reiterated	Needham	Buy
Apr-25-23	Downgrade	BofA Securities	Buy → Underperform
Feb-08-23	Initiated	CapitalOne	Overweight
Feb-03-23	Initiated	Oppenheimer	Perform
Dec-15-22	Initiated	H.C. Wainwright	Buy
Dec-14-22	Initiated	Needham	Buy
Dec-05-22	Initiated	Goldman	Buy
Dec-01-22	Initiated	BofA Securities	Buy

View All

Day One Biopharmaceuticals Inc Stock (DAWN) Latest News

Feb 06, 2025

The Top 12 Companies Hiring in Biopharma Now - BioSpace

Feb 06, 2025

A closer look at Day One Biopharmaceuticals Inc (DAWN)’s stock price trends - US Post News

Feb 06, 2025

Feb 05, 2025

Balance Sheet Insights: Day One Biopharmaceuticals Inc (DAWN)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex

Feb 05, 2025

Financial Metrics Unveiled: Ginkgo Bioworks Holdings Inc (DNA)’s Key Ratios in the Spotlight - The Dwinnex

Feb 05, 2025

How To Trade (DAWN) - Stock Traders Daily

Feb 05, 2025

Feb 04, 2025

You might want to take a look at Day One Biopharmaceuticals Inc (DAWN) now - SETE News

Feb 04, 2025

Feb 03, 2025

Day One Biopharmaceuticals: A Successful Launch In Pediatric Cancer - Seeking Alpha

Feb 03, 2025

Feb 02, 2025

SG Americas Securities LLC Buys Shares of 68,374 Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - MarketBeat

Feb 02, 2025

Jan 30, 2025

The Pediatric Brain Tumor Foundation welcomes Day One Biopharmaceuticals’ renowned Dr. Samuel C. Blackman to its Board of Directors - Yahoo Finance

Jan 30, 2025

Jan 29, 2025

SG Americas Securities LLC Acquires Shares of 68,374 Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World

Jan 29, 2025

Jan 27, 2025

Reviewing Day One Biopharmaceuticals (NASDAQ:DAWN) and Nature’s Sunshine Products (NASDAQ:NATR) - Defense World

Jan 27, 2025

Jan 26, 2025

Critical Survey: Day One Biopharmaceuticals (NASDAQ:DAWN) vs. Annexon (NASDAQ:ANNX) - Defense World

Jan 26, 2025

Jan 25, 2025

(DAWN) Trading Report - Stock Traders Daily

Jan 25, 2025

Jan 23, 2025

Why Is Andreas Halvorsen Bullish On Day One Biopharmaceuticals, Inc. (DAWN) Now? - Yahoo Finance

Jan 23, 2025

Jan 21, 2025